Cargando…
Nucleic Acid-Based Diagnostic Tests for the Detection SARS-CoV-2: An Update
The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began as a cluster of pneumonia cases in Wuhan, China before spreading to over 200 countries and territories on six continents in less than six months. Despite rigorous global containment a...
Autores principales: | Yu, Choo Yee, Chan, Kok Gan, Yean, Chan Yean, Ang, Geik Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823986/ https://www.ncbi.nlm.nih.gov/pubmed/33401392 http://dx.doi.org/10.3390/diagnostics11010053 |
Ejemplares similares
-
Lateral Flow Immunoassays for SARS-CoV-2
por: Ang, Geik Yong, et al.
Publicado: (2022) -
Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics
por: Chan, Kok Gan, et al.
Publicado: (2021) -
Genome Sequences of Two Multidrug-Resistant Proteus mirabilis Strains Harboring CTX-M-65 Isolated from Malaysia
por: Yu, Choo Yee, et al.
Publicado: (2016) -
Genomic Surveillance of SARS-CoV-2 in Malaysia during the Era of Endemic COVID-19
por: Lee, Tze Yan, et al.
Publicado: (2023) -
Draft genome sequence of a multidrug-resistant Chryseobacterium indologenes isolate from Malaysia
por: Yu, Choo Yee, et al.
Publicado: (2015)